is tirzepatide off the shortage list Eli Lilly's weight loss drug no longer in FDA Allows Compounded Tirzepatide During

Reduces Body Fat : Growth hormone helps to break down fat cells and use them for energy

The market is becoming increasingly competitive as pharmaceutical and biotechnology companies accelerate investments in the development of differentiated oral GLP-1 receptor agonists

No cannabis-based medicine is licensed in the UK for obesity management, and NICE does not recommend cannabis for weight loss

That pressure is driven primarily by anti-fat bias masquerading as health

The consistency of GLP-1 effectiveness across alcohol, opioids, cocaine, nicotine, and cannabis suggests these drugs may act on a shared vulnerability underlying addiction not on any single substance pathway